ArticlemedRxiv : the preprint server for health sciences2024
Translational modeling-based evidence for enhanced efficacy of standard-of-care drugs in combination with anti-microRNA-155 in non-small-cell lung cancer.
Prashant Dogra et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.